HEADER HYDROLASE/INHIBITOR 23-APR-19 6OOE TITLE CTX-M-27 BETA LACTAMASE WITH COMPOUND 20 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: CTX-M-27, CTX-M-14LIKE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS BETA-LACTAMASE, ESBL, NON COVALENT COMPLEX, HYDROLASE, HYDROLASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.KEMP,Y.CHEN REVDAT 4 23-OCT-24 6OOE 1 REMARK REVDAT 3 11-OCT-23 6OOE 1 REMARK REVDAT 2 26-AUG-20 6OOE 1 JRNL REVDAT 1 01-JUL-20 6OOE 0 JRNL AUTH K.DEFREES,M.T.KEMP,X.ELHILALI-POLLARD,X.ZHANG,A.MOHAMED, JRNL AUTH 2 Y.CHEN,A.R.RENSLO JRNL TITL AN EMPIRICAL STUDY OF AMIDE-HETEROARENE PI-STACKING JRNL TITL 2 INTERACTIONS USING REVERSIBLE INHIBITORS OF A BACTERIAL JRNL TITL 3 SERINE HYDROLASE. JRNL REF ORG CHEM FRONT V. 6 1749 2019 JRNL REFN ISSN 2052-4110 JRNL PMID 32774871 JRNL DOI 10.1039/C9QO00342H REMARK 2 REMARK 2 RESOLUTION. 1.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.27 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.2 REMARK 3 NUMBER OF REFLECTIONS : 107923 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.145 REMARK 3 R VALUE (WORKING SET) : 0.145 REMARK 3 FREE R VALUE : 0.172 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.860 REMARK 3 FREE R VALUE TEST SET COUNT : 2010 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.2828 - 3.0369 0.89 7656 142 0.1552 0.1714 REMARK 3 2 3.0369 - 2.4107 0.92 7802 151 0.1627 0.1911 REMARK 3 3 2.4107 - 2.1060 0.92 7806 143 0.1456 0.1515 REMARK 3 4 2.1060 - 1.9135 0.87 7370 145 0.1384 0.1430 REMARK 3 5 1.9135 - 1.7763 0.89 7572 137 0.1398 0.2059 REMARK 3 6 1.7763 - 1.6716 0.92 7813 150 0.1298 0.1745 REMARK 3 7 1.6716 - 1.5879 0.92 7806 148 0.1192 0.1485 REMARK 3 8 1.5879 - 1.5188 0.92 7782 146 0.1188 0.1641 REMARK 3 9 1.5188 - 1.4603 0.87 7362 143 0.1283 0.1723 REMARK 3 10 1.4603 - 1.4099 0.86 7289 131 0.1330 0.1724 REMARK 3 11 1.4099 - 1.3658 0.88 7381 148 0.1365 0.1731 REMARK 3 12 1.3658 - 1.3268 0.88 7432 148 0.1430 0.1878 REMARK 3 13 1.3268 - 1.2918 0.89 7511 144 0.1550 0.2050 REMARK 3 14 1.2918 - 1.2603 0.87 7331 134 0.1746 0.2019 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OOE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-APR-19. REMARK 100 THE DEPOSITION ID IS D_1000240966. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 206742 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.260 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.10600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.1700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.67400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4UA6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0 M POTASSIUM PHOSPHATE, PH 7.9, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 53.74100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PCA B 25 REMARK 465 THR B 26 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 53 1.92 -156.31 REMARK 500 CYS A 69 -138.93 49.11 REMARK 500 VAL A 103 -132.53 -106.70 REMARK 500 TYR A 105 96.57 -161.34 REMARK 500 SER A 220 -127.70 -104.49 REMARK 500 GLN A 254 107.36 -54.47 REMARK 500 CYS B 69 -138.78 49.04 REMARK 500 VAL B 103 -129.27 -108.78 REMARK 500 TYR B 105 99.98 -160.52 REMARK 500 SER B 220 -127.75 -105.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 747 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH A 748 DISTANCE = 6.53 ANGSTROMS REMARK 525 HOH B 781 DISTANCE = 6.49 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R6Z A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R6Z A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R6Z B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R6Z B 302 DBREF 6OOE A 25 290 UNP I7AP60 I7AP60_ECOLX 22 284 DBREF 6OOE B 25 290 UNP I7AP60 I7AP60_ECOLX 22 284 SEQADV 6OOE PCA A 25 UNP I7AP60 GLN 22 CONFLICT SEQADV 6OOE HIS A 99 UNP I7AP60 PRO 95 CONFLICT SEQADV 6OOE PCA B 25 UNP I7AP60 GLN 22 CONFLICT SEQADV 6OOE HIS B 99 UNP I7AP60 PRO 95 CONFLICT SEQRES 1 A 263 PCA THR SER ALA VAL GLN GLN LYS LEU ALA ALA LEU GLU SEQRES 2 A 263 LYS SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASP SEQRES 3 A 263 THR ALA ASP ASN THR GLN VAL LEU TYR ARG GLY ASP GLU SEQRES 4 A 263 ARG PHE PRO MET CYS SER THR SER LYS VAL MET ALA ALA SEQRES 5 A 263 ALA ALA VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU SEQRES 6 A 263 LEU ASN GLN PRO VAL GLU ILE LYS HIS ALA ASP LEU VAL SEQRES 7 A 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 A 263 MET THR LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 A 263 SER ASP ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU SEQRES 10 A 263 GLY GLY PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE SEQRES 11 A 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 A 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 A 263 THR PRO ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR SEQRES 14 A 263 LEU GLY HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU SEQRES 15 A 263 VAL THR TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 A 263 ILE ARG ALA GLY LEU PRO THR SER TRP THR VAL GLY ASP SEQRES 17 A 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE SEQRES 18 A 263 ALA VAL ILE TRP PRO GLN GLY ARG ALA PRO LEU VAL LEU SEQRES 19 A 263 VAL THR TYR PHE THR GLN PRO GLN GLN ASN ALA GLU SER SEQRES 20 A 263 ARG ARG ASP VAL LEU ALA SER ALA ALA ARG ILE ILE ALA SEQRES 21 A 263 GLU GLY LEU SEQRES 1 B 263 PCA THR SER ALA VAL GLN GLN LYS LEU ALA ALA LEU GLU SEQRES 2 B 263 LYS SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASP SEQRES 3 B 263 THR ALA ASP ASN THR GLN VAL LEU TYR ARG GLY ASP GLU SEQRES 4 B 263 ARG PHE PRO MET CYS SER THR SER LYS VAL MET ALA ALA SEQRES 5 B 263 ALA ALA VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU SEQRES 6 B 263 LEU ASN GLN PRO VAL GLU ILE LYS HIS ALA ASP LEU VAL SEQRES 7 B 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 B 263 MET THR LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 B 263 SER ASP ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU SEQRES 10 B 263 GLY GLY PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE SEQRES 11 B 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 B 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 B 263 THR PRO ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR SEQRES 14 B 263 LEU GLY HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU SEQRES 15 B 263 VAL THR TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 B 263 ILE ARG ALA GLY LEU PRO THR SER TRP THR VAL GLY ASP SEQRES 17 B 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE SEQRES 18 B 263 ALA VAL ILE TRP PRO GLN GLY ARG ALA PRO LEU VAL LEU SEQRES 19 B 263 VAL THR TYR PHE THR GLN PRO GLN GLN ASN ALA GLU SER SEQRES 20 B 263 ARG ARG ASP VAL LEU ALA SER ALA ALA ARG ILE ILE ALA SEQRES 21 B 263 GLU GLY LEU HET PCA A 25 8 HET R6Z A 301 29 HET R6Z A 302 29 HET R6Z B 301 29 HET R6Z B 302 29 HETNAM PCA PYROGLUTAMIC ACID HETNAM R6Z 3-(1H-TETRAZOL-5-YL)-N-[3-(1H-TETRAZOL-5-YL)PHENYL]-5- HETNAM 2 R6Z (TRIFLUOROMETHYL)BENZAMIDE FORMUL 1 PCA C5 H7 N O3 FORMUL 3 R6Z 4(C16 H10 F3 N9 O) FORMUL 7 HOH *729(H2 O) HELIX 1 AA1 SER A 27 GLY A 41 1 15 HELIX 2 AA2 CYS A 69 THR A 71 5 3 HELIX 3 AA3 SER A 72 GLU A 85 1 14 HELIX 4 AA4 GLN A 89 ASN A 92 5 4 HELIX 5 AA5 LYS A 98 LEU A 102 5 5 HELIX 6 AA6 ILE A 108 VAL A 113 5 6 HELIX 7 AA7 LEU A 119 SER A 130 1 12 HELIX 8 AA8 ASP A 131 LEU A 142 1 12 HELIX 9 AA9 GLY A 144 ILE A 155 1 12 HELIX 10 AB1 PRO A 167 THR A 171 5 5 HELIX 11 AB2 THR A 182 LEU A 195 1 14 HELIX 12 AB3 GLY A 200 GLY A 213 1 14 HELIX 13 AB4 SER A 220 LEU A 225 5 6 HELIX 14 AB5 ARG A 275 GLY A 289 1 15 HELIX 15 AB6 ALA B 28 GLY B 41 1 14 HELIX 16 AB7 CYS B 69 THR B 71 5 3 HELIX 17 AB8 SER B 72 GLU B 85 1 14 HELIX 18 AB9 GLN B 89 ASN B 92 5 4 HELIX 19 AC1 LYS B 98 LEU B 102 5 5 HELIX 20 AC2 ILE B 108 VAL B 113 5 6 HELIX 21 AC3 LEU B 119 SER B 130 1 12 HELIX 22 AC4 ASP B 131 LEU B 142 1 12 HELIX 23 AC5 GLY B 144 ILE B 155 1 12 HELIX 24 AC6 PRO B 167 THR B 171 5 5 HELIX 25 AC7 THR B 182 LEU B 195 1 14 HELIX 26 AC8 GLY B 200 GLY B 213 1 14 HELIX 27 AC9 SER B 220 LEU B 225 5 6 HELIX 28 AD1 ARG B 275 GLY B 289 1 15 SHEET 1 AA1 5 GLN A 56 TYR A 60 0 SHEET 2 AA1 5 ARG A 43 ASP A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 AA1 5 LEU A 259 THR A 266 -1 O TYR A 264 N GLY A 45 SHEET 4 AA1 5 THR A 243 TRP A 251 -1 N ILE A 250 O LEU A 259 SHEET 5 AA1 5 THR A 230 GLY A 238 -1 N THR A 230 O TRP A 251 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 AA3 2 PRO A 94 ILE A 97 0 SHEET 2 AA3 2 GLY A 115 THR A 118 -1 O GLY A 115 N ILE A 97 SHEET 1 AA4 5 GLN B 56 TYR B 60 0 SHEET 2 AA4 5 ARG B 43 ASP B 50 -1 N VAL B 46 O TYR B 60 SHEET 3 AA4 5 LEU B 259 THR B 266 -1 O THR B 266 N ARG B 43 SHEET 4 AA4 5 THR B 243 TRP B 251 -1 N ILE B 250 O LEU B 259 SHEET 5 AA4 5 THR B 230 GLY B 238 -1 N THR B 230 O TRP B 251 SHEET 1 AA5 2 PHE B 66 PRO B 67 0 SHEET 2 AA5 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 AA6 2 PRO B 94 ILE B 97 0 SHEET 2 AA6 2 GLY B 115 THR B 118 -1 O GLY B 115 N ILE B 97 LINK C PCA A 25 N THR A 26 1555 1555 1.33 CISPEP 1 GLU A 166 PRO A 167 0 3.51 CISPEP 2 GLU B 166 PRO B 167 0 7.35 SITE 1 AC1 13 ASN A 104 TYR A 105 SER A 130 THR A 216 SITE 2 AC1 13 SER A 237 SER A 274 ARG A 276 R6Z A 302 SITE 3 AC1 13 HOH A 439 HOH A 459 HOH A 482 HOH A 488 SITE 4 AC1 13 HOH A 605 SITE 1 AC2 19 ASN A 104 TYR A 105 SER A 130 ASN A 132 SITE 2 AC2 19 PRO A 167 ASN A 170 THR A 171 THR A 235 SITE 3 AC2 19 GLY A 236 SER A 237 GLY A 238 GLY A 240 SITE 4 AC2 19 GLN A 270 R6Z A 301 HOH A 414 HOH A 439 SITE 5 AC2 19 HOH A 459 HOH A 666 HOH A 702 SITE 1 AC3 11 ASN B 104 TYR B 105 SER B 130 THR B 216 SITE 2 AC3 11 SER B 237 SER B 274 ARG B 276 R6Z B 302 SITE 3 AC3 11 HOH B 441 HOH B 442 HOH B 503 SITE 1 AC4 18 ASN B 104 TYR B 105 SER B 130 ASN B 132 SITE 2 AC4 18 PRO B 167 ASN B 170 THR B 171 THR B 235 SITE 3 AC4 18 GLY B 236 SER B 237 GLY B 238 GLY B 240 SITE 4 AC4 18 ARG B 256 R6Z B 301 HOH B 441 HOH B 442 SITE 5 AC4 18 HOH B 535 HOH B 697 CRYST1 45.323 107.482 48.057 90.00 101.72 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022064 0.000000 0.004575 0.00000 SCALE2 0.000000 0.009304 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021251 0.00000 HETATM 1 N PCA A 25 14.515 77.506 27.153 1.00 33.52 N ANISOU 1 N PCA A 25 4636 3475 4626 -1126 1895 -129 N HETATM 2 CA PCA A 25 15.075 76.652 26.109 1.00 32.44 C ANISOU 2 CA PCA A 25 4413 3395 4518 -1205 1821 11 C HETATM 3 CB PCA A 25 16.487 76.220 26.486 1.00 32.93 C ANISOU 3 CB PCA A 25 4505 3444 4561 -1168 1779 -59 C HETATM 4 CG PCA A 25 16.602 76.420 27.986 1.00 33.90 C ANISOU 4 CG PCA A 25 4722 3487 4670 -1117 1760 -131 C HETATM 5 CD PCA A 25 15.447 77.339 28.270 1.00 34.39 C ANISOU 5 CD PCA A 25 4813 3518 4735 -1090 1867 -182 C HETATM 6 OE PCA A 25 15.326 77.904 29.361 1.00 35.25 O ANISOU 6 OE PCA A 25 5057 3554 4782 -1048 1963 -268 O HETATM 7 C PCA A 25 14.246 75.391 25.917 1.00 30.52 C ANISOU 7 C PCA A 25 4009 3276 4310 -1293 1716 237 C HETATM 8 O PCA A 25 13.501 74.990 26.808 1.00 30.79 O ANISOU 8 O PCA A 25 3993 3307 4400 -1356 1718 373 O